13 August 2026

PBS Pharmaceuticals

GBMA targets medicine shortages

13 August 2026

Immunotherapy PBS

Chemo-free immunotherapy combo for follicular lymphoma gets PBS listing

16 July 2026

Breast cancer PBS Pharmaceuticals

AstraZeneca announces new access program for cancer implant

4 June 2026

Leukaemia PBS Pharmaceuticals

PBS listing opens access to breakthrough therapy

7 May 2026

PBS TGA

New cancer drug subsidies and registrations

23 April 2026

PBS Pharmaceuticals

Aussie-made hereditary angioedema therapy gains PBS listing

9 April 2026

Cancer PBS

PBS expands pembrolizumab access for three cancers

4 December 2025

PBS Pharmaceuticals

Green light for first targeted therapy for relapsed myeloma

3 December 2025

PBS Pharmaceuticals

Frontline myeloma therapy lands on the PBS

6 November 2025

PBS Pharmaceuticals

New PBS listing for front-line lymphoma therapy

5 June 2025

Lung cancer PBS Pharmaceuticals

Targeted lung cancer therapy added to PBS

24 April 2025

Cancer PBS

Aussie myelofibrosis drug added to PBS

17 October 2024

Haematology Leukaemia PBS

Combination blood cancer treatment added to PBS

5 September 2024

PBS Pharmaceuticals

Expanded PBS listing for cabozantinib

8 August 2024

Gastrointestinal cancer Immune Checkpoint Inhibitors Lung cancer PBS

New PBS listings for lung, urothelial and liver cancer

13 June 2024

Diabetes PBS Pharmaceuticals Political

PBS rejigs rules on GLP-1s and other diabetes meds

8 February 2024

Immunotherapy Melanoma & skin cancer PBS Pharmaceuticals

Melanoma drug newly listed on PBS